Relmada Therapeutics (RLMD) Earnings (2012 - 2026)
Relmada Therapeutics (RLMD) earnings from Feb 29, 2012 to Mar 31, 2026. The TTM Relmada Therapeutics (RLMD) earnings is -$59M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Earnings
Quarterly Earnings
Relmada Therapeutics (RLMD) Earnings CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -22.24% |
| 3 Years TTM | -25.71% |
| 5 Years TTM | -3.67% |
| All Time TTM | +94.17% |
Annual Earnings change of Relmada Therapeutics (RLMD)
| Year | Earnings | Change |
|---|---|---|
| 2026 | -$19M | -66.81% |
| 2025 | -$57M | -28.24% |
| 2024 | -$80M | -19.04% |
| 2023 | -$99M | -37.09% |
| 2022 | -$157M | +24.88% |
| 2021 | -$126M | +111.49% |
| 2020 | -$59M | +296.14% |
| 2019 | -$15M | +67.52% |
| 2018 | -$8.96M | +42.45% |
| 2017 | -$6.29M | +111.78% |
| 2016 | -$2.97M | -85.72% |
| 2015 | -$21M | -14.68% |
| 2014 | -$24M | +22.70% |
| 2013 | -$20M | +198600.00% |
| 2012 | -$10K | N/A |
| 2011 | $0 | N/A |
Comparison Relmada Therapeutics (RLMD) five years earnings CAGR with competitors
Relmada Therapeutics (RLMD) five years earnings CAGR is -3.67%.